Gene	Mutation	ProtMut	MutReads	WTReads	VAF	Info
CBFB-MYH11	CBFB-MYH11_chr16-chr16_PE	PE	11	286_84	NA	Oncogenic
CBFB-MYH11	CBFB:chr16:67082307-MYH11:chr16:15732564	CBFB.A166-MYH11.A1225	41	38-2	NA	Oncogenic
CSF3R	chr1:36467309-36467311_Del:CTG	R653-K654_Del:NR	42	264	0.137	Neutral
DNMT3A	chr2:25235821-25235825_Del:CTGAA	F827fs*25	5	150	0.032	Oncogenic
ETV6	chr12:11650159-11752450_Del:AGC	E12_Del:Q	8	70	0.103	Neutral
FLT3	chr13:28023477-28028287_ITD	E762-D763_Ins:EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFHRTWTEIFKEHNFSFYPTFQSHPNSSMPGSREVQIHPDSDQISGLHGNSFHSE	7	88	0.074	Oncogenic
FLT3	chr13:28050157-28050157_Sub:G>A	T227M	91	83	0.523	Neutral
GNAS	chr20:58898985-58898985_Ins:GCA	G728-E729_Ins:S	23	94	0.197	Neutral
KIT	chr4:54699764-54699764_Ins:CAG	Q251-T252_Ins:Q	6	69	0.080	Neutral
KIT	chr4:54729485-54731329_Del:GCA	D715_Del:S	14	34	0.292	Neutral
KMT2A	chr11:118471919-118471919_Ins:A	I256fs*1	5	145	0.033	Sequencing_artefact
KMT2A	chr11:118472296-118472296_Ins:A	A383fs*5	8	85	0.086	Sequencing_artefact
KMT2A	chr11:118473980-118473980_Sub:T>C	S941P	4	135	0.029	Neutral
KMT2A	chr11:118488759-118489792_Del:AGC	L1494_Del:Q	9	152	0.056	Neutral
KMT2A	chr11:118491308-118491316_Del:AGGTACAGA	T1604-D1606_Del:GTE	26	2	0.929	Neutral
KMT2A	chr11:118505073-118505073_Sub:C>T	Q3061*	4	148	0.026	Neutral
KMT2A	chr11:118505200-118505200_Ins:A	I3105fs*7	6	68	0.081	Sequencing_artefact
PHF6	chrX:134393951-134393951_Ins:AGC	A139-D140_Ins:A	33	183	0.153	Neutral
PTPN11	chr12:112446397-112450318_Del:AGA	N47_Del:R	11	328	0.032	Neutral
SF3B1	chr2:197401451-197401451_Ins:A	F815fs*1	37	876	0.041	Sequencing_artefact
SF3B1	chr2:197416765-197416765_Ins:T	K214fs*20	28	768	0.035	Sequencing_artefact
STAG2	chrX:124086710-124086710_Ins:A	S1075fs*11	9	395	0.022	Sequencing_artefact
TET2	chr4:105275672-105275672_Sub:T>G	L1721W	53	49	0.520	Neutral
TP53	chr17:7676154-7676154_Sub:G>C	P72R	210	0	1.000	Neutral
WT1	chr11:32389178-32391978_Del:ACTTGTTTT	T476-E478_Del:KTS	7	23	0.233	Neutral